World Oncology Information System Market - Opportunities and Forecasts, 2014 - 2022

  • ID: 3773460
  • Report
  • Region: Global
  • 184 pages
  • Allied Analytics LLP
1 of 4
Oncology information systems is a software that is used to manage extensive cancer patient data and oversee procedures associated with oncology care. The advantages of using oncology information systems such as cost-saving, future-proofing, and environment-friendly, has increased the pressure on healthcare organization to upgrade their procedure from paper-based to paperless systems. The global oncology information systems market was valued at $2,247 million in 2015, and is estimated to reach $3,755 million by 2022, registering a CAGR of 7.5% 2016 to 2022.

The global oncology information systems market is segmented based on products and services, applications, end user, and geography. Based on products and services, it is classified into software and services. Software segment is further bifurcated into patient information systems and treatment planning systems. Services are further segmented into consulting/optimization services, implementation services, and post-sale and maintenance services. Based on applications, it is categorized into radiation, medical, and surgical oncology. Based on end users, it is bifurcated into hospitals and oncology clinics, and research centers. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market growth is attributed to the surge in prevalence of cancer and technological advancements in oncology information systems, and the increase in disposable income among these patients. The benefits of using oncology information systems over conventional methods of record maintenance and treatment procedures, and rise in the healthcare expenditure are expected to increase the demand for these systems, thus fueling the market growth. However, dearth of healthcare IT professionals and high costs associated with oncology information systems are expected to hamper the growth.

KEY MARKET BENEFITS

This report offers a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to products and services, application, end user, and geography.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY PLAYERS PROFILED

Accuray Incorporated
Bogardus Medical Systems, Inc.
Cerner Corporation
CureMD Corporation
Elekta AB
Flatiron Health, Inc.
Koninklijke Philips N.V.
McKesson Corporation
RaySearch Laboratories AB
Varian Medical Systems, Inc.

KEY MARKET SEGMENTS

By Products and Services

Software
Patient Information Systems
Treatment Planning Systems
Services
Consulting/Optimization Services
Implementation Services
Post-sale & Maintenance Services

By Application

Radiation Oncology
Medical Oncology
Surgical Oncology

By End User

Hospitals and Oncology Clinics
Research Centers

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Republic of South Africa
Saudi Arabia
Rest of LAMEA

The other players of the catheters market include (companies not profiled in the report):

IMPAC Medical Systems, Inc.
Siemens Healthcare
Epic Systems Corporation
Bizmatics, Inc.
Charm Health
Cordata Healthcare Innovations, LLC.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. KEY ONCOLOGY INFORMATION SYSTEMS AVAILABLE IN THE MARKET
3.5. MARKET SHARE ANAYSIS, 2016
3.6. REGULATION OF ONCOLOGY INFORMATION SYSTEM
3.7. MARKET DYNAMICS
3.7.1. Drivers
3.7.1.1. Availability of OIS with improved features
3.7.1.2. Increase in prevalence of cancer cases
3.7.1.3. Advantages of OIS over conventional record maintenance practices
3.7.2. Restraints
3.7.2.1. Dearth of healthcare IT professionals
3.7.2.2. High costs associated with OIS systems
3.7.3. Opportunities
3.7.3.1. Untapped potential of emerging markets
3.7.3.2. Use of artificial intelligence (AI) in oncology information systems

CHAPTER 4 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SOFTWARE
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Patient information systems
4.2.4.1. Market size and forecast
4.2.5. Treatment planning systems
4.2.5.1. Market size and forecast
4.3. SERVICE
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Consulting/Optimization services
4.3.4.1. Market size and forecast
4.3.5. Implementation services
4.3.5.1. Market size and forecast
4.3.6. Post-sale & maintenance services
4.3.6.1. Market size and forecast

CHAPTER 5 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. MEDICAL ONCOLOGY
5.2.1. Market size and forecast
5.3. RADIATION ONCOLOGY
5.3.1. Market size and forecast
5.4. SURGICAL ONCOLOGY
5.4.1. Market size and forecast

CHAPTER 6 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS & ONCOLOGY CLINICS
6.2.1. Market size and forecast
6.3. RESEARCH CENTERS
6.3.1. Market size and forecast

CHAPTER 7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES
8.1. ACCURAY INCORPORATED
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BOGARDUS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. CERNER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. CURE MD CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments
8.5. ELEKTA AB
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. FLATIRON HEALTH, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. MCKESSON CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. RAYSEARCH LABORATORIES AB
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. VARIAN MEDICAL SYSTEMS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

List of Tables
Table 1. Global Oncology Information Systems Market, By Product & Service, 2014-2022 ($Million)
Table 2. Global Oncology Information System Software Market, By Type, 2014-2022 ($Million)
Table 3. Oncology Information System Software Market, By Geography, 2014-2022 ($Million)
Table 4. Oncology Information Systems Patient Information Systems Market, By Geography, 2014-2022 ($Million)
Table 5. Oncology Information Systems Treatment Planning Systems Market, By Geography, 2014-2022 ($Million)
Table 6. Global Oncology Information System Service Market, By Type, 2014-2022 ($Million)
Table 7. Oncology Information System Service Market, By Geography, 2014-2022 ($Million)
Table 8. Oncology Information System Consulting Services Market, By Geography, 2014-2022 ($Million)
Table 9. Oncology Information System Implementation Services Market, By Geography, 2014-2022 ($Million)
Table 10. Oncology Information System Maintenance Services Market, By Geography, 2014-2022 ($Million)
Table 11. Global Oncology Information Systems Market, By Application, 2014-2022 ($Million)
Table 12. Medical Oncology Information Systems Market, By Geography, 2014-2022 ($Million)
Table 13. Radiation Oncology Information Systems Market, By Geography, 2014-2022 ($Million)
Table 14. Surgical Oncology Information Systems Market, By Geography, 2014-2022 ($Million)
Table 15. Global Oncology Information Systems Market, By End USer, 2014-2022 ($Million)
Table 16. Oncology Information Systems Market For Hospitals & Oncology Clinics, By Geography, 2014-2022 ($Million)
Table 17. Oncology Information Systems Market For Research Centers, By Geography, 2014-2022 ($Million)
Table 18. Oncology Information Systems Market, By Geography, 2014-2022 ($Million)
Table 19. North America Oncology Information Systems Market, By Country, 2014-2022 ($Million)
Table 20. North America Oncology Information Systems Market, By Product & Service, 2014-2022 ($Million)
Table 21. North America Oncology Information Systems Software Market, By Type, 2014-2022 ($Million)
Table 22. North America Oncology Information Systems Services Market, By Type, 2014-2022 ($Million)
Table 23. North America Oncology Information Systems Market, By Application, 2014-2022 ($Million)
Table 24. North America Oncology Information Systems Market, By End USer, 2014-2022 ($Million)
Table 25. Europe Oncology Information Systems Market, By Country, 2014-2022 ($Million)
Table 26. Europe Oncology Information Systems Market, By Product & Service, 2014-2022 ($Million)
Table 27. Europe Oncology Information Systems Software Market, By Type, 2014-2022 ($Million)
Table 28. Europe Oncology Information Systems Services Market, By Type, 2014-2022 ($Million)
Table 29. Europe Oncology Information Systems Market, By Application, 2014-2022 ($Million)
Table 30. Europe Oncology Information Systems Market, By End USer, 2014-2022 ($Million)
Table 31. Asia-Pacific Oncology Information Systems Market, By Country, 2014-2022 ($Million)
Table 32. Asia-Pacific Oncology Information Systems Market, By Product & Service, 2014-2022 ($Million)
Table 33. Asia-Pacific Oncology Information Systems Software Market, By Type, 2014-2022 ($Million)
Table 34. Asia-Pacific Oncology Information Systems Services Market, By Type, 2014-2022 ($Million)
Table 35. Asia-Pacific Oncology Information Systems Market, By Application, 2014-2022 ($Million)
Table 36. Asia-Pacific Oncology Information Systems Market, By End USer, 2014-2022 ($Million)
Table 37. Lamea Oncology Information Systems Market, By Country, 2014-2022 ($Million)
Table 38. Lamea Oncology Information Systems Market, By Product & Service, 2014-2022 ($Million)
Table 39. Lamea Oncology Information Systems Software Market, By Type, 2014-2022 ($Million)
Table 40. Lamea Oncology Information Systems Services Market, By Type, 2014-2022 ($Million)
Table 41. Lamea Oncology Information Systems Market, By Application, 2014-2022 ($Million)
Table 42. Lamea Oncology Information Systems Market, By End USer, 2014-2022 ($Million)
Table 43. Accuray: Company Snapshot
Table 44. Accuray: Operating Segments
Table 45. Accuray: Product Portfolio
Table 46. Bogardus: Company Snapshot
Table 47. Bogardus: Operating Segments
Table 48. Cerner: Company Snapshot
Table 49. Cerner: Operating Segments
Table 50. Cerner: Product Portfolio
Table 51. Cure Md: Company Snapshot
Table 52. Cure Md: Operating Segments
Table 53. Elekta: Company Snapshot
Table 54. Elekta: Operating Segments
Table 55. Elekta: Product Portfolio
Table 56. Flatiron Health: Company Snapshot
Table 57. Flatiron Health: Operating Segments
Table 58. Philips: Company Snapshot
Table 59. Philips: Operating Segments
Table 60. Philips: Product Portfolio
Table 61. Mckesson: Company Snapshot
Table 62. Mckesson: Operating Segments
Table 63. Mckesson: Product Portfolio
Table 64. Raysearch: Company Snapshot
Table 65. Raysearch: Product Portfolio
Table 66. Varian: Company Snapshot
Table 67. Varian: Operating Segments
Table 68. Varian: Product Portfolio

List of Figures
Figure 1. Market Segmentation
Figure 2. Top Investment Pockets In Global Oncology Information System Market
Figure 3. Top Winning Strategies: Percentage Distribution (2015-2017) (%)
Figure 4. Top Winning Strategies In Oncology Information Systems Market (2015-2017)
Figure 5. Top Winning Strategies: Type And Nature
Figure 6. Bargaining Power Of Buyers
Figure 7. Bargaining Power Of Suppliers
Figure 8. Threat Of New Entrants
Figure 9. Threat Of Substitution
Figure 10. Competitive Rivalry
Figure 11. Market Share Analysis: Global Oncology Information Systems Market, 2016
Figure 12. Global Oncology Information Systems Market: Restraints And Drivers
Figure 13. Global Oncology Information Systems Market Segmentation, By Application
Figure 14. U.S. Oncology Information Systems Market, 2014-2022 ($Million)
Figure 15. Canada Oncology Information Systems Market, 2014-2022 ($Million)
Figure 16. Mexico Oncology Information Systems Market, 2014-2022 ($Million)
Figure 17. Germany Oncology Information Systems Market, 2014-2022 ($Million)
Figure 18. France Oncology Information Systems Market, 2014-2022 ($Million)
Figure 19. UK Oncology Information Systems Market, 2014-2022 ($Million)
Figure 20. Italy Oncology Information Systems Market, 2014-2022 ($Million)
Figure 21. Rest Of Europe Oncology Information Systems Market, 2014-2022 ($Million)
Figure 22. Japan Oncology Information Systems Market, 2014-2022 ($Million)
Figure 23. China Oncology Information Systems Market, 2014-2022 ($Million)
Figure 24. Australia Oncology Information Systems Market, 2014-2022 ($Million)
Figure 25. India Oncology Information Systems Market, 2014-2022 ($Million)
Figure 26. Rest Of Asia-Pacific Oncology Information Systems Market, 2014-2022 ($Million)
Figure 27. Brazil Oncology Information Systems Market, 2014-2022 ($Million)
Figure 28. Turkey Oncology Information Systems Market, 2014-2022 ($Million)
Figure 29. Saudi Arabia Oncology Information Systems Market, 2014-2022 ($Million)
Figure 30. South Africa Oncology Information Systems Market, 2014-2022 ($Million)
Figure 31. Rest Of Lamea Oncology Information Systems Market, 2014-2022 ($Million)
Figure 32. Accuray: Revenue, 2014-2016 ($Million)
Figure 33. Accuray: Revenue Share By Geography, 2016 (%)
Figure 34. Cerner: Revenue, 2014-2016 ($Million)
Figure 35. Cerner: Revenue By Segment, 2016 (%)
Figure 36. Elekta: Revenue, 2014-2016 ($Million)
Figure 37. Elekta: Revenue Share By Product Type, 2016 (%)
Figure 38. Elekta: Revenue Share By Geography, 2016 (%)
Figure 39. Philips: Revenue, 2014-2016 ($Million)
Figure 40. Philips: Revenue Share By Segment, 2016 (%)
Figure 41. Philips: Revenue Share By Geography, 2016 (%)
Figure 42. Mckesson: Revenue, 2014-2016 ($Million)
Figure 43. Mckesson: Revenue By Segment, 2016 (%)
Figure 44. Mckesson: Revenue By Geography, 2016 (%)
Figure 45. Raysearch: Revenue, 2014-2016 ($Million)
Figure 46. Raysearch: Revenue Share By Geography, 2015 (%)
Figure 47. Varian: Revenue, 2014-2016 ($Million)
Figure 48. Varian: Revenue Share By Segment, 2016 (%)
Figure 49. Varian: Revenue Share By Geography, 2016 (%)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Oncology Information System Market Report, forecasts that the global market was valued at $2,247 million in 2015 and is expected to garner $3,755 million by 2022, registering a CAGR of 7.5% during the forecast period 2016 - 2022. North America is the highest contributor in the oncology information systems market; however, Asia-Pacific is witnessing the highest growth rate.

Oncology information systems enable management of patient profiles by combining surgical, radiation, and medical oncology information in one system. Moreover, these systems facilitate management of treatment plans and schedules of cancer patients, and predict the results of the treatments. Safety and efficiency of cancer treatment is improved by use of these systems owing to their ability to predict the treatment outcome.

The benefits of implementing oncology information systems over conventional methods of record keeping and treatment planning are expected to boost the growth of the oncology information systems market. The advantages of oncology information systems such as planned treatment, future-proofing, and remote access are expected to increase the demand for these systems and motivate the government organizations to upgrade their procedure from paper-based systems to paperless systems. Furthermore, the increase in disposable income among cancer patients, surge in prevalence of cancer cases, and technological advancements in these systems, such as incorporation of patient portals, are anticipated to fuel the market growth. Rise in healthcare expenditure in developing countries, such as India and China, advancement in software using artificial intelligence, and use of oncology information systems to treat rare cancers are expected to present multiple opportunities for market growth. However, this growth is restricted owing to lack of healthcare IT professionals and high capital costs associated with oncology information systems.

Among the product & service segment, software for patient information system was the largest revenue contributor in 2015 towards market growth, and is anticipated to continue this trend in the future. Advantages of using these systems as compared to conventional record maintenance methods such as planned treatment and remote access due to digital availability are expected to boost the growth of this segment.

Medical oncology dominates the oncology information systems market. In medical oncology, oncology information systems software manages, interprets, analyzes, and stores the patient information efficiently. In addition, as the software assists to predict the treatment outcome for patients, it helps to improve the survival rate of the patient and drives the oncology information systems market growth.

In 2015, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer and high adoption rate of technologically advanced products. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in disposable income, increase in government initiatives to modernize healthcare infrastructure, and rise in healthcare expenditure.

Key Findings of Oncology Information System Market:

Research centers segment is projected to grow at the highest rate during the analysis period.
Hospitals and oncology clinics was the highest revenue-generating segment, and is expected to continue its dominance in future.
North America dominated global oncology information systems market, and is projected to grow at a CAGR of 7%.
China is expected to grow highest in the Asia-Pacific region, registering a CAGR of 15.7%.
Treatment planning systems segment was the fastest growing segment growing at a CAGR of 8.2%.

The key companies profiled in the report include Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical Systems, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll